ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 1,001 filers reported holding ASTRAZENECA PLC in Q2 2022. The put-call ratio across all filers is 1.36 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $213,386 | -6.2% | 3,151 | -0.9% | 0.05% | +2.0% |
| Q2 2023 | $227,522 | -6.8% | 3,179 | -9.6% | 0.05% | -13.6% |
| Q1 2023 | $244,115 | +9.6% | 3,517 | +7.0% | 0.06% | +7.3% |
| Q4 2022 | $222,791 | -77.3% | 3,286 | -77.8% | 0.06% | -69.4% |
| Q2 2022 | $980,000 | +9.4% | 14,835 | +9.8% | 0.18% | +18.4% |
| Q1 2022 | $896,000 | +3.3% | 13,507 | -6.4% | 0.15% | -2.6% |
| Q3 2021 | $867,000 | +7.3% | 14,437 | +7.0% | 0.16% | +2.6% |
| Q2 2021 | $808,000 | +10.8% | 13,497 | -8.0% | 0.15% | +0.7% |
| Q1 2021 | $729,000 | -2.7% | 14,673 | -2.0% | 0.15% | -10.1% |
| Q4 2020 | $749,000 | -2.6% | 14,980 | +6.8% | 0.17% | -15.2% |
| Q3 2020 | $769,000 | +58.2% | 14,025 | +52.7% | 0.20% | +7.6% |
| Q2 2020 | $486,000 | +38.1% | 9,185 | +16.6% | 0.18% | +18.7% |
| Q1 2020 | $352,000 | +146.2% | 7,874 | +174.0% | 0.16% | +171.9% |
| Q4 2019 | $143,000 | – | 2,874 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 75,000 | $3,351,000 | 5.64% |
| Galibier Capital Management Ltd. | 276,112 | $12,331,000 | 5.37% |
| Hansberger Growth Investors, LP | 72,860 | $3,254,000 | 4.39% |
| Sivik Global Healthcare LLC | 75,000 | $10,145,000 | 4.00% |
| Eversept Partners, LP | 352,551 | $15,744,928 | 3.91% |
| Integral Health Asset Management, LLC | 190,000 | $8,485,000 | 3.74% |
| Pictet North America Advisors SA | 231,691 | $20,731,000 | 3.54% |
| SPHERA FUNDS MANAGEMENT LTD. | 570,000 | $25,456,000 | 3.18% |
| ZWJ INVESTMENT COUNSEL INC | 720,181 | $32,163,000 | 2.87% |
| CRAWFORD INVESTMENT COUNSEL INC | 1,906,718 | $85,154,000 | 2.86% |